Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: New suggestions

International Journal of Infectious Diseases

Volumn 16, Issue 2, 2012, Pages

  Ozturk, Baris ^a   Tutuncu, Ediz ^a   Kuscu, Ferit ^a   Gurbuz, Yunus ^a   Sencan, Irfan ^a   Tuzun, Hakan ^b  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever; Fatality; Prognosis

Indexed keywords

ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; D DIMER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; PREALBUMIN; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CRIMEAN CONGO HEMORRHAGIC FEVER; DEATH; DIARRHEA; EPISTAXIS; FATIGUE; FEMALE; FEVER; FOLLOW UP; GINGIVA BLEEDING; HEADACHE; HEMATEMESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MELENA; MYALGIA; NAUSEA; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE; PROGNOSIS; PROTHROMBIN TIME; REAL TIME POLYMERASE CHAIN REACTION; SKIN BLEEDING; THROMBOCYTE COUNT; VAGINA BLEEDING;

ADULT; ALANINE TRANSAMINASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASES; C-REACTIVE PROTEIN; CERULOPLASMIN; COMPLEMENT C3; COMPLEMENT C4; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERNATIONAL NORMALIZED RATIO; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PREALBUMIN; PROGNOSIS; PROTEIN C; PROTEIN S; PROTHROMBIN TIME;

EID: 84856008409     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.06.005     Document Type: Article

References (15)

1. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006, 6:203-214.
2. Whitehouse C.A. Crimean-Congo haemorrhagic fever. Antiviral Res 2004, 64:145-160.
3. Tarantola A., Ergonul O., Tattevin P. Estimates and prevention of Crimean Congo hemorrhagic fever risks for health care workers. Crimean Congo hemorrhagic fever: a global perspective 2007, 281-294. Springer, Dordrecht. O. Ergonul, C.A. Whitehouse (Eds.).
4. Marty A.M., Jahrling P.B., Geisbert T.W. Viral hemorrhagic fevers. Clin Lab Med 2006, 26:345-386.
5. Mardani M., Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med 2007, 10:204-214.
6. Swanepoel R., Gill D.E., Shepherd A.J., Leman P.A., Mynhardt J.H., Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989, 11:794-800.
7. Bakir M., Ugurlu M., Dokuzoguz B., Bodur H., Tasyaran M.A., Vahaboglu H., et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 2005, 54:385-389.
8. Ergonul O., Celikbas A., Baykam N., Eren S., Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006, 12:551-554.
9. Cevik M.A., Erbay A., Bodur H., Gülderen E., Baştuĝ A., Kubar A., et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008, 12:374-379.
10. Tasdelen Fisgin N., Tanyel E., Doganci L., Tulek N. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever. Trop Doct 2009, 39:158-160.
11. Turkish Ministry of Health. Kirim Kongo Kanamali ateşi: 2002-2009 yillari vaka sayilari. Ankara, Turkey: Ministry of Health; 2011. Available at: .(accessed March 11, 2011). http://www.saglik.gov.tr/KKKA/belge/1-6590/kirim-kongo-kanamali-atesi-vaka-ve-olumlerinin-yillara-html.
12. Yilmaz G.R., Buzgan T., Irmak H., Safran A., Uzun R., Cevik M.A., et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis 2009, 13:380-386.
13. Cevik M.A., Erbay A., Bodur H., Eren S.S., Akinci E., Sener K., et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 2007, 45:96-100.
14. Celikbas A., Ergonul O., Baykam N., Eren S., Esener H., Dokuzoguz B. Analysis of the mortality among the patients with Crimean Congo hemorrhagic fever virus infection. 15th European Congress of Clinical Microbiology and Infectious Diseases, April 2-5, 2005, Copenhagen. Clin Microbiol Infect 2005, 11(Suppl 2):19.
15. Ergonul O., Tuncbilek S., Baykam N., Celikbas A., Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006, 193:941-944.